Post-op shoe market seen reaching $1.1 billion by 2031
Allied Market Research projects the global post-op shoe market will grow from $634.5 million in 2021 to $1.1 billion by 2031, driven by demand from adult patients, semi-rigid designs and medical and pharma stores. North America leads now, while Asia-Pacific is expected to post the fastest growth.
Why it matters: - The post-op shoe market is expanding as foot and ankle injuries, surgeries and recovery needs support steady demand. - The market’s growth could shape product development, distribution strategies and regional expansion for manufacturers and retailers. - Adult patients represent the largest end-user opportunity, which matters because that segment is tied to the highest revenue base and a 5.2% forecast CAGR.
What happened: - Allied Market Research valued the global post-op shoe market at $634.50 million in 2021. - The firm expects the market to reach $1.1 billion by 2031. - The forecast implies a 5.1% CAGR from 2022 to 2031. - The report identifies post-op shoes as products used after surgery or for foot and ankle injuries. - Europe and North America account for the widest usage, followed by Asia-Pacific.
The details: - The market is segmented by type, end user, distribution channel and region. - Product types include rigid sole, soft sole and semi-rigid sole. - End users are split between adults and children. - Distribution channels include medical and pharma stores, specialty stores and online retail. - Regions analyzed include North America, Europe, Asia-Pacific and LAMEA. - The semi-rigid post-op shoe segment was valued at $298.1 million in 2021. - Allied Market Research expects semi-rigid shoes to reach $492.7 million by 2031. - That segment is projected to grow at a 5.2% CAGR. - The adult end-user segment is expected to grow at a 5.2% CAGR during the forecast period. - Adult products generate the largest revenue share because foot and ankle injuries are more common among adults. - The medical and pharma store channel was valued at $266.0 million in 2021. - The channel is projected to reach $438.1 million by 2031. - That distribution segment is expected to grow at a 5.1% CAGR. - Product variety in medical and pharma stores is one factor behind that growth. - North America holds the largest global market share and is expected to keep that lead through 2031. - Asia-Pacific is expected to post the strongest growth rate. - The report links North America's lead to rapid technological development in post-op shoe products. - The report points to broader product offerings as a growth driver in Asia-Pacific. - Examples of post-op shoes in the market include adjustable Darco med post-op surg shoe, Darco slimline cast boot, EZ Walking foot and ankle support cast boot, canvas rocker bottom cast shoe and pediatric classic post op shoe with buckle closure. - During the COVID-19 pandemic, supply-chain disruptions, border restrictions and trade barriers created pressure on manufacturers and exporters. - Lockdowns and retail closures hurt on-premise sales, while online retail helped market penetration. - The pandemic had a negative impact on the post-op shoe market. - Key market strategies include product launches and geographic expansion. - Product innovation is a priority for major players. - Key companies named in the report include A. Algeo Ltd., Bird and Cronin, LLC., Breg, Inc., DJO, LLC, DoctorschoiceDME, Henry Schein, Inc., Össur, Safte S.p.A., Steeper Inc. and Chengli Medical Equipment Co., Ltd. - The report offers a sample PDF, a purchase inquiry option and related report links, including the diabetic socks market and the tactical footwear market.
Between the lines: - The report suggests the market is competitive but still fragmented enough for product differentiation to matter. - Semi-rigid models stand out as the largest type segment, which signals demand for products that balance support and flexibility. - Online retail gained importance during the pandemic, hinting that multichannel distribution may remain important even as stores recover.
What's next: - Manufacturers are likely to keep prioritizing new product launches and geographic expansion. - Asia-Pacific may become a more important growth engine if current demand trends continue. - The report’s forecast suggests steady, mid-single-digit growth rather than a rapid market surge. - More information is available through the report sample and purchase inquiry page.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
World Healthcare Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.